ReviewCureus2025
The Integration of Artificial Intelligence Into Precision Medicine for Neuro-Oncology: Ethical, Clinical, and Nursing Implications in Immunotherapy Care.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Ethical challenges in the algorithmic era: a systematic rapid review of risk insights and governance pathways for nursing predictive analytics and early warning systems.BMC medical ethics · 2025Pooled it
- Nursing roles, competencies, and education in precision oncology: a scoping review.EClinicalMedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper explores how artificial intelligence (AI) is being woven into precision medicine for neuro-oncology, highlighting its ethical, clinical, and nursing implications in the realm of immunotherapy. With AI-powered diagnostics and predictive analytics, we're seeing a boost in treatment accuracy, which paves the way for more personalized and effective care. On the clinical side, AI is fine-tuning targeted therapies, leading to better patient outcomes and less treatment-related toxicity. However, ethical concerns pop up around data privacy, algorithmic bias, and fair access to these AI-driven treatments. Nurses are at the forefront of tackling these issues, ensuring that care remains patient-centered, monitoring AI-assisted interventions, and grappling with ethical challenges. Their role in education and advocacy is crucial in connecting the dots between AI innovations and compassionate care. As AI continues to advance, it's vital for different disciplines to work together to tap into its potential while maintaining ethical standards and enhancing care in neuro-oncology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.